Skip to main content
SpringerLink
Log in

Protein kinase CK2: Signaling and tumorigenesis in the mammary gland

  • Chapter
Protein Kinase CK2 — From Structure to Regulation

Part of the book series: Molecular and Cellular Biochemistry ((DMCB,volume 35))

Abstract

Breast cancer is a major cause of cancer death in women, and the genetic abnormalities leading to the common sporadic forms of the disease are still under active investigation. CK2 has been reported to be upregulated in human breast cancer, which these studies confirm; CK2 is also upregulated in rat carcinogen-induced breast tumors. Transgenic mice overexpressing CK2α in the mammary gland develop mammary hyperplasia, dysplasia, and eventually adenocarcinomas, demonstrating that dysregulated expression of CK2 can contribute to transformation of the mammary epithelium. These mammary tumors have evidence of activation of the Wnt and NFκB pathways and upregulation of c-Myc. CK2 is capable of phosphorylating the key signaling molecule in the Wnt pathway, the transcriptional cofactor β-catenin, and regulating its turnover. CK2 is known to phosphorylate IKB and thereby regulate basal NFκB levels; in the mammary cell lines and tumors, CK2 activity correlates with NFκB levels and inhibition of CK2 downregulates NFκB. Thus, CK2 may promote breast cancer through dysregulation of key pathways of transcriptional control in the mammary epithelium, and inhibition of CK2 has a potential role in the treatment of breast and other cancers. (Mol Cell Biochem 227: 153-165, 2001)

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Xu X, Toselli PA, Russell LD, Seldin DC: Globozoospermia in mice lacking the casein kinase II alpha’ catalytic subunit. Nat Genet 23: 118–121, 1999

    Article  PubMed  CAS  Google Scholar 

  2. Seldin DC, Leder P: Casein kinase II alpha transgene-induced murine lymphoma: Relation to theileriosis in cattle. Science 267: 894–897,1995

    Article  PubMed  CAS  Google Scholar 

  3. Kelliher MA, Seldin DC, Leder P: Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha. Embo J 15: 5160–5166, 1996

    Google Scholar 

  4. Landesman-Bollag E, Channavajhala PL, Cardiff RD, Seldin DC: p53 deficiency and misexpression of protein kinase CK2alpha collaborate in the development of thymic lymphomas in mice. Oncogene 16: 2965–2974, 1998

    Article  PubMed  CAS  Google Scholar 

  5. Allende JE, Allende CC: Protein kinases. 4. Protein kinase CK2: An enzyme with multiple substrates and a puzzling regulation. FASEB J 9: 313–323, 1995

    PubMed  CAS  Google Scholar 

  6. Pinna LA, Meggio F: Protein kinase CK2 (`casein kinase-2’) and its implication in cell division and proliferation. Prog Cell Cycle Res 3: 77–97, 1997

    Article  PubMed  CAS  Google Scholar 

  7. Kim DW, Sovak MA, Zanieski G, Nonet G, Romieu-Mourez R, Lau AW, Hafer LJ, Yaswen P, Stampfer M, Rogers AE, Russo J, Sonenshein GE: Activation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cells. Carcinogenesis 21: 871–879, 2000

    Article  PubMed  Google Scholar 

  8. Sinn E, Muller W, Pattengale P, Tepler I, Wallace R, Leder P: Co-expression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo. Cell 49: 465–475, 1987

    Article  PubMed  CAS  Google Scholar 

  9. Sinn E, Muller W, Pattengale P, Tepler I, Wallace R, Leder P: Co-expression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo. Cell 49: 465–475, 1987 http://www mp.ucdavis.edu/tgmice/firststop.html

    Article  PubMed  CAS  Google Scholar 

  10. Kuenzel EA, Mulligan JA, Sommercorn J, Krebs EG: Substrate specificity determinants for casein kinase II as deduced from studies with synthetic peptides. J Biol Chem 262: 9136–9140, 1987

    PubMed  CAS  Google Scholar 

  11. Duyao MP, Buckler AJ, Sonenshein GE: Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter. Proc Natl Acad Sci U S A 87: 4727–4731, 1990

    Article  PubMed  CAS  Google Scholar 

  12. Arsura M, FitzGerald MJ, Fausto N, Sonenshein GE: Nuclear factorkappaB/Rel blocks transforming growth factor betal-induced apoptosis of murine hepatocyte cell lines. Cell Growth Differ 8: 1049–1059, 1997

    PubMed  CAS  Google Scholar 

  13. Huggins C, Grand LC, Brillantes FP: Mammary cancer induced by a single feeding of polynuclear hydrocarbons, and its suppression. Nature 189: 204–207, 1961

    Article  PubMed  CAS  Google Scholar 

  14. Rogers, BH: Dimethylbenzanthracene-induced mammary tumorigenesis in ethanol-fed rats. Nutr Res 10: 143–146, 1990

    Article  Google Scholar 

  15. Stewart TA, Pattengale PK, Leder P: Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/ myc fusion genes. Cell 38: 627–637, 1984

    Article  PubMed  CAS  Google Scholar 

  16. Cardiff RD: The biology of mammary transgenes: Five rules. J Mammary Gland Biol Neoplas 1: 61–73, 1996

    Article  CAS  Google Scholar 

  17. Mahler JF, Stokes W, Mann PC, Takaoka M, Maronpot RR: Spontaneous lesions in aging FVB/N mice. Toxicol Pathol 24: 710–716, 1996

    Article  PubMed  CAS  Google Scholar 

  18. Cardiff RD, Wellings SR: The comparative pathology of human and mouse mammary glands. J Mammary Gland Biol Neoplas 4: 105–122, 1999

    Article  CAS  Google Scholar 

  19. Willert K, Brink M, Wodarz A, Varmus H, Nusse R: Casein kinase 2 associates with and phosphorylates dishevelled. Embo J 16: 3089–3096, 1997

    Article  PubMed  CAS  Google Scholar 

  20. Pando MP, Verma IM: Signal-dependent and -independent degradation of free and NF-kappa B-bound Ikappa Balpha. J Biol Chem 275: 21278–21286, 2000

    Article  Google Scholar 

  21. Janosch P, Schellerer M, Seitz T, Reim P, Eulitz M, Brielmeier M, Kolch W, Sedivy JM, Mischak H: Characterization of IkappaB kinases. IkappaB-alpha is not phosphorylated by Raf-1 or protein kinase C isozymes, but is a casein kinase II substrate. J Biol Chem 271: 13868–13874, 1996

    Article  PubMed  CAS  Google Scholar 

  22. Schwarz EM, Van AD, Verma IM: Constitutive phosphorylation of IkappaBalpha by casein kinase II occurs preferentially at serine 293: Requirement for degradation of free IkappaBalpha. Mol Cell Biol 16: 3554–3559, 1996

    PubMed  CAS  Google Scholar 

  23. McElhinny JA, Trushin SA, Bren GD, Chester N, Paya CV: Casein kinase II phosphorylates I kappa B alpha at S-283, S-289, S-293, and T291 and is required for its degradation. Mol Cell Biol 16: 899–906, 1996

    PubMed  CAS  Google Scholar 

  24. Foo SY, Nolan GP: NF-kappaB to the rescue: RELs, apoptosis and cellular transformation. Trends Genet 15: 229–235, 1999

    Article  PubMed  CAS  Google Scholar 

  25. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ Jr, Sledge GW Jr: Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 17: 3629–3639, 1997

    PubMed  CAS  Google Scholar 

  26. Romieu-Mourez R, Landesman-Bollag E, Seldin DC, Traish AM, Mercurio F, Sonenshein GE: Roles of IKK kinases and protein kinase CK2 in activation of NF-kB in breast cancer. Cancer Res (in press)

    Google Scholar 

  27. Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM, Sonenshein GE: Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. J Clin Invest 100: 2952–2960, 1997

    Article  PubMed  CAS  Google Scholar 

  28. Howard DK, Schlom J, Fisher PB: Chemical carcinogen-mouse mammary tumor virus interactions in cell transformation. In Vitro 19: 5866, 1983

    Article  Google Scholar 

  29. Kessler DJ, Duyao MP, Spicer DB, Sonenshein GE: NF-kappa B-like factors mediate interleukin 1 induction of c-myc gene transcription in fibroblasts. J Exp Med 176: 787–792, 1992

    Article  PubMed  CAS  Google Scholar 

  30. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW: Identification of c-MYC as a target of the APC pathway. Science 281: 1509–1512, 1998

    Article  PubMed  CAS  Google Scholar 

  31. Serres M, Grangeasse C, Haftek M, Durocher Y, Duclos B, Schmitt D: Hyperphosphorylation of beta-catenin on serine-threonine residues and loss of cell-cell contacts induced by calyculin A and okadaic acid in human epidermal cells. Exp Cell Res 231: 163–172, 1997

    Article  PubMed  CAS  Google Scholar 

  32. Agullo G, Gamet-Payrastre L, Manenti S, Viala C, Remesy C, Chap H, Payrastre B: Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: A comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol 53: 1649–1657, 1997

    Article  PubMed  CAS  Google Scholar 

  33. Munstermann U, Fritz G, Seitz G, Lu YP, Schneider HR, Issinger OG: Casein kinase II is elevated in solid human tumours and rapidly proliferating non-neoplastic tissue. Eur J Biochem 189: 251–257, 1990

    Article  PubMed  CAS  Google Scholar 

  34. Ohi Y, Yoshida H: Influence of estrogen and progesterone on the induction of mammary carcinomas by 7,12-dimethylbenz(a)anthracene in ovariectomized rats. Virchows Arch B Cell Pathol Incl Mol Pathol 62: 365–370, 1992

    Article  PubMed  CAS  Google Scholar 

  35. Tsukamoto AS, Grosschedl R, Guzman RC, Parslow T, Varmus HE: Expression of the int-1 gene in transgenic mice is associated with 165 mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 55: 619–625, 1988

    Article  PubMed  CAS  Google Scholar 

  36. Barker N, Huls G, Korinek V, Clevers H: Restricted high level expression of Tcf-4 protein in intestinal and mammary gland epithelium. Am J Pathol 154: 29–35, 1999

    Article  Google Scholar 

  37. Bui TD, Rankin J, Smith K, Huguet EL, Ruben S, Strachan T, Harris AL, Lindsay S: A novel human Wnt gene, WNT10B, maps to 12q13 and is expressed in human breast carcinomas. Oncogene 14: 1249–1253,1997

    Article  PubMed  CAS  Google Scholar 

  38. Dale TC, Weber-Hall SJ, Smith K, Huguet EL, Jayatilake H, Gusterson BA, Shuttleworth G, O’Hare M, Harris AL: Compartment switching of WNT-2 expression in human breast tumors. Cancer Res 56: 4320–4323, 1996

    PubMed  Google Scholar 

  39. Huguet EL, McMahon JA, McMahon AP, Bicknell R, Harris AL: Differential expression of human Wnt genes 2, 3, 4, and 7B in human breast cell lines and normal and disease states of human breast tissue. Cancer Res 54: 2615–2621, 1994

    PubMed  CAS  Google Scholar 

  40. Israel A: The IKK complex: An integrator of all signals that activate NF-kappaB? Trends Cell Biol 10: 129–133, 2000

    Article  PubMed  CAS  Google Scholar 

  41. Bren GD, Pennington KN, Paya CV: PKC-zeta-associated CK2 participates in the turnover of free IkappaBalpha. J Mol Biol 297: 1245–1258, 2000

    Article  Google Scholar 

  42. Heilker R, Freuler F, Pulfer R, Di Padova F, Eder J: All three IkappaB isoforms and most Rel family members are stably associated with the IkappaB kinase 1/2 complex. Eur J Biochem 259: 253–261, 1999

    Article  PubMed  CAS  Google Scholar 

  43. Tran K, Merika M, Thanos D: Distinct functional properties of IkappaB alpha and IkappaB beta. Mol Cell Biol 17: 5386–5399, 1997

    PubMed  CAS  Google Scholar 

  44. Lin R, Beauparlant P, Makris C, Meloche S, Hiscott J: Phosphorylation of IkappaBalpha in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability. Mol Cell Biol 16: 1401–1409, 1996

    PubMed  CAS  Google Scholar 

  45. Bird TA, Schooley K, Dower S K, Hagen H, Virca G D: Activation of nuclear transcription factor NF-kappaB by interleukin-1 is accompanied by casein kinase II-mediated phosphorylation of the p65 subunit. J Biol Chem 272: 32606–32612, 1997

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Pathology, Boston University School of Medicine, Boston, MA, USA

    Esther Landesman-Bollag

  2. Department of Chemistry, Boston University, Boston, MA, USA

    Diane H. Song

  3. Department of Biochemistry, Boston University School of Medicine, Boston, MA, USA

    Raphaelle Romieu Mourez & Gail E. Sonenshein

  4. Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, College Park, MD, USA

    Daniel J. Sussman

  5. Center for Comparative Medicine, U.C. Davis School of Medicine, Davis, CA, USA

    Robert D. Cardiff

  6. Departments of Medicine and Microbiology, Boston University School of Medicine, Boston, MA, USA

    David C. Seldin

Authors
  1. Esther Landesman-Bollag
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Diane H. Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Raphaelle Romieu Mourez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daniel J. Sussman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Robert D. Cardiff
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gail E. Sonenshein
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. David C. Seldin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cellular and Molecular Biochemistry Research Lab, University of Minnesota, Veterans Affairs Medical Center, One Veterans Drive, Minneapolis, 55417, MN, USA

    Khalil Ahmed

  2. Department of Biochemistry and Molecular Biology, University of Southern Denmark, Campusvej 55, 5230, Odense, Denmark

    Olaf-Georg Issinger

  3. Program de Biologia Celular y Molecular, Instituto de Ciencias Biomedicas, Facultad de Medicina, Universidad de Chile, 70086, Casilla, Santiago 7, Chile

    Jorge E Allende

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media New York

About this chapter

Cite this chapter

Landesman-Bollag, E. et al. (2001). Protein kinase CK2: Signaling and tumorigenesis in the mammary gland. In: Ahmed, K., Issinger, OG., Allende, J.E. (eds) Protein Kinase CK2 — From Structure to Regulation. Molecular and Cellular Biochemistry, vol 35. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1723-8_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-1723-8_19

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5696-7

  • Online ISBN: 978-1-4615-1723-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation